Records containing: Thymic Carcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-27Postoperative Adjuvant Treatment for Thymic Cancer With Completed Resection (Radiotherapy vs Chemoradiotherapy): A Prospective, Multicenter, Open-label, Phase III, Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2026-04-24A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy
-
CLINICAL_TRIALS study record update · 2026-03-23A Multicenter, Phase II Trial of Pembrolizumab and Sunitinib in Refractory Advanced Thymic Carcinoma
-
CLINICAL_TRIALS study record update · 2026-03-18A Single-Arm, Prospective, Phase II Trial of Adebrelimab Plus Albumin-Bound Paclitaxel, Cisplatin, and Concurrent Radiotherapy for Neoadjuvant Treatment of Locally Advanced Thymic Carcinoma
-
CLINICAL_TRIALS study record update · 2026-02-05Prospective Cohort Study of Electrocautery Resection Combined With Hyperthermic Intrathoracic Chemotherapy for Thymic Epithelial Tumors With Pleural Metastasis
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-27A Phase II Parallel Arm Study of SACITUZUMAB GOVITECAN-HZIY in Patients With Advanced Thymoma and Thymic Carcinoma
-
CLINICAL_TRIALS study record update · 2026-01-09A Phase II Clinical Study of Sacituzumab Tirumotecan in Participants With Locally Advanced or Metastatic Thymic Carcinoma With Treatment Failure After Platinum-Based Therapy
-
CLINICAL_TRIALS study record update · 2026-01-07A Phase II Trial of Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma (BMS #CA225-331/Lilly Trial Alias I4E-US-X007)
-
CLINICAL_TRIALS study record update · 2025-12-26Molecular Analysis of Thoracic Malignancies
-
CLINICAL_TRIALS study record update · 2025-12-01Tislelizumab Combined With Anlotinib as Second-line Therapy in Thymoma and Thymic Carcinoma: An Open-label, Single-centre, Phase 2 Study
-
CLINICAL_TRIALS study record update · 2025-10-02Clinical Study of CD70-Targeted Chimeric Antigen Receptor T Lymphocytes (CAR-T) in Advanced CD70-Positive Malignant Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-09-17Survival Nomogram for Patients With Thymic Carcinoma
-
CLINICAL_TRIALS study record update · 2025-05-22Molecular Landscape Analysis and Treatment Options for Thymic Epithelial Tumors
-
CLINICAL_TRIALS study record update · 2024-10-08Phase 1/2 Study to Evaluate the Safety and Preliminary Activity of Nivolumab in Combination With Vorolanib in Patients With Refractory Thoracic Tumors
-
CLINICAL_TRIALS study record update · 2024-05-29Improving Treatment Strategies in Thymic Epithelial Tumors: a TYME Collaborative Effort
-
CLINICAL_TRIALS study record update · 2024-05-10Postoperative Adjuvant Treatment for Thymic Cancer With Completed Resection (Radiotherapy vs Chemoradiotherapy): A Prospective, Multicenter, Open-label, Phase III, Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-04-16Phase II Study of KN046 in Patients With Thymic Carcinoma Who Failed Immune Checkpoint Inhibitors
-
CLINICAL_TRIALS study record update · 2024-03-27Artificial Intelligence for Histopathological Classification and Recurrence Prediction of Thymic Epithelial Tumors
-
CLINICAL_TRIALS study record update · 2024-03-12A Phase 2, Open-Label, Multi-Center Study to Evaluate Efficacy, Safety and Tolerability of KN046 in Subjects With Thymic Carcinoma
-
CLINICAL_TRIALS study record update · 2023-09-06Clinical Study of Envolizumab Combined With Radiotherapy for Neoadjuvant Treatment of Locally Advanced Thymic Cancer
-
CLINICAL_TRIALS study record update · 2023-02-21Single-arm, Multicentre, Phase II Study of Immunotherapy in Patients With Type B3 Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy
-
CLINICAL_TRIALS study record update · 2023-01-18A Phase 1, Open Label, Multi-Center, Single and Multiple Dose, Dose Escalation and Expansion Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S in Previously Treated Patients With Advanced or Metastatic Cancers With High LAT1 Signatures, and in Patients With Relapsed or Refractory Grade 4 Astrocytoma
-
CLINICAL_TRIALS study record update · 2022-12-01A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2022-09-10An Open-label Phase II Study of Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy - RESOUND
-
CLINICAL_TRIALS study record update · 2021-06-09Phase II Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines (Style Trial)